AIkido Pharma Inc. (NASDAQ:AIKI) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 1,990,000 shares, a growth of 267.1% from the March 15th total of 542,100 shares. Based on an average daily trading volume, of 15,570,000 shares, the short-interest ratio is presently 0.1 days. Approximately 5.7% of the shares of the company are sold short.
Shares of NASDAQ:AIKI opened at $0.97 on Tuesday. The company has a 50-day simple moving average of $1.19 and a 200-day simple moving average of $1.32. AIkido Pharma has a one year low of $0.47 and a one year high of $2.74.
An institutional investor recently bought a new position in AIkido Pharma stock. Virtu Financial LLC bought a new stake in AIkido Pharma Inc. (NASDAQ:AIKI) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 88,326 shares of the business services provider’s stock, valued at approximately $77,000. Virtu Financial LLC owned about 0.25% of AIkido Pharma as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 1.64% of the company’s stock.
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Featured Article: How a Put Option Works
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.